期刊文献+

CTMAB增敏荧光光度法测定牛奶中莫西沙星残留量 被引量:1

CTMAB Sensitization Fluorophotometric Determination of Residual Moxifloxacin in Milk
下载PDF
导出
摘要 基于在pH 5.00的柠檬酸盐缓冲溶液中,十六烷基三甲基溴化铵(CTMAB)可使莫西沙星(MXFX)-钇(Ⅲ)反应体系的荧光强度显著增敏,提出了荧光光度法测定牛奶中MXFX残留量的分析方法。在292nm(λ_(ex))及483nm(λ_(em))波长处,所测得的相对荧光强度与MXFX的质量浓度在50~800μg·L^(-1)范围内呈线性关系。方法的检出限(3σ)为46.2μg·L^(-1)。方法用于牛奶中MXFX的测定,测得方法的平均回收率为92.8%,测定值的相对标准偏差(n=5)均小于3%。 Based on the sensitizing action of cetyltrimethylammonium bromide(CTMAB) on the fluorescence intensity emitted by the reaction system of moxifloxacin(MXFX) and Y(Ⅲ) in a citrate buffer solution of pH 5.00, a fluorophotometric method for determination of residual amount of MXFX in milk was proposed.Linear relationship was found between values of average relative fluorescence intensity.I_f measured at wavelengths of 292 nm(λ_(ex)) and 483 nm(λ_(em)) and concentration of MXFX in the range of 50-800μg·L^(-1).Limit of detection (3σ) found was 46.2μg·L^(-1).The proposed method was used in the determination of MXFX in samples of milk, giving values of average recovery of 92.8%,and of RSD's(n= 5) less than 3%.
出处 《理化检验(化学分册)》 CAS CSCD 北大核心 2011年第7期797-798,801,共3页 Physical Testing and Chemical Analysis(Part B:Chemical Analysis)
基金 河南省高等学校骨干教师资助计划项目(2009GGJS-196) 平顶山市科技攻关计划项目(2010080)
关键词 荧光光度法 莫西沙星 十六烷基三甲基溴化铵 增敏 Fluorophotometry Moxifloxacin Cetyltrimethylammonium bromide Sensitization
  • 相关文献

参考文献4

二级参考文献18

  • 1罗兰 谭仁祥.抗抑郁药的药理学研究进展[J].药理学研究进展,2000,:75-82.
  • 2[1]Woodcock J M, Andrews J M, Boswell F J. et al. In vitro activity of BAY 12-8039, a new fluoroquinolone [J]. Antimicrob AgentsChemother , 1997;41:1101
  • 3[2]Hoogkamp-Korstanje J A, Roelofs-Winemse J. Comparative invitro activity of moxitloxacin against Gram-positive clinical isolates[J]. J Antimicrob Chemother, 2000; 45 (1): 31
  • 4[3]Sunderland J, Tobin C M, Hedges A J, et al. Antimicrobial activity of fluoroquinolone photodegradation products determinated byparallel-line bioassay and high performance liquid chromatography[J]. JAntimicrob Chemother, 2001; 47 (3): 271
  • 5[4]Stass H, Kubitza D. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administation in man [J]. JAntimicrob Chemother, 1999; 43 (Supple B): 83
  • 6[5]Stass H, Dalhoff A. Determination of BAY12-8039, a new 8methoxyquinolone, in human body fluids by high-performance liqnid chromatography with fluorescence detection using on-columnfocusing [J]. J Chromatogr Biomed Appl, 1997; 702 ( 1 ~ 2):163
  • 7[6]Moller J G, Stass H, Heinig R, et al. Capillary electrophoresiswith laser-induced fluorescence: a routine method to determinemoxifloxacin in human body fluids in very small sample volumes[J]. J Chromatog, 1998; 716:325
  • 8Clau D T W, Femandes P B. Antimicrob Agents Chemother, 1989, 33(2) : 131.
  • 9Renyi L, Evenden J L, Fowler C J. J pharaeol Exp Ther, 2001,299(3) :881.
  • 10Millan M J, Gobert A, Lejeune F et al. J pharacol Exp Ther, 2001,298 (2) : 565.

共引文献43

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部